Invisalign® System with Mandibular Advancement

Trial statusRecruiting
Trial phaseNot applicable
Trial typeInterventional
Biological sexAll
Age10-16
SponsorAlign Technology, Inc.

About this trial

The goal of this clinical trial is to observe study participants' comfort and fit of their aligners with occlusal blocks, as well as evaluate the engagement of the blocks using the Invisalign® System with mandibular advancement featuring occlusal blocks

Eligibility criteria

This trial does not accept healthy volunteers

Qualifiers

None

Disqualifiers

Subject's dentition not compatible with device or allergy to device materials

Subject who is pregnant, has active caries, periodontal disease, TMD, root resorption, has HAE (hereditary angioedema), has been diagnosed with epilepsy or any other seizure disorder

Trial design

Design model

Single group

Treatments tested in this trial

  • Invisalign® System with mandibular advancement featuring occlusal blocks

    Device

    Class II correction using the Invisalign® System with mandibular advancement featuring occlusal blocks

Treatment groups

36 Participants
are divided into 1 treatment group
Group A: Invisalign® System with Mandibular AdvancementExperimental treatment 1 intervention

Trial outcomes

Primary outcomes

1

Comfort and fit

Measured using quality of life surveys at the insertion, interim, and end of study visits. Measured on a scale which the subject rates from 1-Always to 5-Never on their current experience.

Time frame
Through the study completion of up to 2 years

Secondary outcomes

1

Class II correction

measured through analysis of intraoral scans

Time frame
Through the study completion of up to 2 years

Other outcomes

1

Class II correction

measured through analysis of cephalometric radiographs

Time frame
Through the study completion of up to 2 years

Sponsors and contacts

Click on the lead sponsor to view all of their trials.